The effect of purslane seeds on glycemic status and lipid profiles of persons with type 2 diabetes: A randomized controlled cross-over clinical trial

Journal of Research in Medical Sciences

Volumn 20, Issue 1, 2015, Pages 47-53

  Esmaillzadeh, Ahmad ^a   Zakizadeh, Elahe ^b,c   Faghihimani, Elham ^d   Gohari, Mahmoodreza ^c   Jazayeri, Shima ^b,c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Glycemia; Hyperlipidemia; Medicinal plant; Purslane

Indexed keywords

PLANT EXTRACT; PURSLANE EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PLANT SEED; PORTULACACEAE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TELEPHONE INTERVIEW; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 84924973130     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Maiti R, Jana D, Das UK, Ghosh D. Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats. J Ethnopharmacol 2004;92:85-91.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
3. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 2008;31:96-8.
4. Bate KL, Jerums G. 3: Preventing complications of diabetes. Med J Aust 2003;179:498-503.
5. Das K, Dang R, Bhaskaran S, Roopashree T, Singh V, Govil J, et al. Recent advances in medicinal plants in diabetes treatment. Phytopharmacology and therapeutic values I. 2008;19:151-91.
6. Watkins PJ. ABC of diabetes: Retinopathy. BMJ 2003;326:924-6.
7. Akhtar MS, Ali MR. Study of anti diabetic effect of a compound medicinal plant prescription in normal and diabetic rabbits. J Pak Med Assoc 1984;34:239-44.
8. Liu L, Howe P, Zhou YF, Xu ZQ, Hocart C, Zhan R. Fatty acids and beta-carotene in australian purslane (Portulaca oleracea) varieties. J Chromatogr A 2000;893:207-13.
9. Simopoulos AP, Norman HA, Gillaspy JE, Duke JA. Common purslane: A source of omega-3 fatty acids and antioxidants. J Am Coll Nutr 1992;11:374-82.
10. Zhang Y, Chen J, Ma XM, Shi YP. Simultaneous determination of flavonoids in Ixeridium gracile by micellar electrokinetic chromatography. J Pharm Biomed Anal 2007;45:742-6.
11. Popp-Snijders C, Schouten JA, Heine RJ, van der Meer J, van der Veen EA. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 1987;4:141-7.
12. Song Y, Manson JE, Buring JE, Sesso HD, Liu S. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: A prospective study and cross-sectional analysis. J Am Coll Nutr 2005;24:376-84.
13. Hasanain B, Mooradian AD. Antioxidant vitamins and their influence in diabetes mellitus. Curr Diab Rep 2002;2:448-56.
14. Levy Y, Zaltsberg H, Ben-Amotz A, Kanter Y, Aviram M. Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus. Ann Nutr Metab 2000;44:54-60.
15. Pazdro R, Burgess JR. The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev 2010;131:276-86.
16. Movahedian A, Ghannadi A, Vashirnia M. Hypocholesterolemic effects of purslane extract on serum lipids in rabbits fed with high cholesterol levels. Int J Pharmacol 2007;3:285-9.
17. Changizi-Ashtiyani S, Zarei A, Taheri S, Rasekh F, Ramazani M. The effects of Portulaca oleracea alcoholic extract on induced hypercholesteroleomia in rats. Zahedan J Res Med Sci 2013;15:34-9.
18. Gong F, Li F, Zhang L, Li J, Zhang Z, Wang G. Hypoglycemic effects of crude polysaccharide from Purslane. Int J Mol Sci 2009;10:880-8.
19. Heidarzadeh S, Farzanegi P, Azarbayjani MA, Daliri R. Purslane effect on GLP-1 and GLP-1 receptor in type 2 diabetes. Electron Physician 2013;5:582-7.
20. Lan S, Fu-er L. Effects of Portulaca oleracea on insulin resistance in rats with type 2 diabetes mellitus. Chin J Integr Med 2003;9:289-92.
21. El-Sayed MI. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol 2011;137:643-51.
22. Fleiss JL. Design and Analysis of Clinical Experiments. Hoboken, New Jersey: Wiley-Interscience; 2011.
23. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62-9.
24. Moreau AG, Savage G. Oxalate content of purslane leaves and the effect of combining them with yoghurt or coconut products. J Food Compost Anal 2009;22:303-6.
25. Yen GC, Chen HY, Peng HH. Evaluation of the cytotoxicity, mutagenicity and antimutagenicity of emerging edible plants. Food Chem Toxicol 2001;39:1045-53.
26. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: An update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-504.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
28. Oliveira I, Valentão P, Lopes R, Andrade PB, Bento A, Pereira JA. Phytochemical characterization and radical scavenging activity of Portulaca oleraceae L. leaves and stems. Microchem J 2009;92:129-34.
29. Abdalla HM Jr. Purslane extract effects on obesity-induced diabetic rats fed a high-fat diet. Malays J Nutr 2010;16:419-29.
30. Besong S, Ezekwe M, Ezekwe E. Evaluating the effects of freezedried supplements of purslane (Portulaca oleracea) on blood lipids in hypercholesterolemic adults. Int J Nutr Metab 2011;3:43-9.
31. Gatreh-Samani K, Farrokhi E, Khalili B, Rafieian M, Moradi M. Purslane (Portulaca oleracea) effects on serum paraoxanase-1 activity. J Shahrekord Univ Med Sci 2011;13:9-14.
32. Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol 2006;33:842-6.
33. Dweck A. Purslane (Portulaca oleracea)-the global panacea. Pers Care Mag 2001;2:7-15.
34. Ryle PR, Barker J, Gaines PA, Thomson AD, Chakraborty J. Alloxan-induced diabetes in the rat — protective action of (−) epicatechin? Life Sci 1984;34:591-5.
35. Lim GE, Brubaker PL. Glucagon-like peptide 1 secretion by the L-cell the view from within. Diabetes 2006;55 Suppl 2: S70-7.
36. Xu X, Yu L, Chen G. Determination of flavonoids in Portulaca oleracea L. by capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal 2006;41:493-9.
37. da Silva RR, de Oliveira TT, Nagem TJ, Pinto AS, Albino LF, de Almeida MR, et al. Hypocholesterolemic effect of naringin and rutin flavonoids. Arch Latinoam Nutr 2001;51:258-64.
38. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 1993;342:1007-11.
39. McKenney JM, Sica D. Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health Syst Pharm 2007;64:595-605.
40. Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 2011;93:243-52.